Perrigo Company plc

Valuation Analysis

About the Company

Perrigo Company plc en bref

Perrigo Company plc (PRGO) is currently trading at 8,94 € with a market capitalization of 1,2 Md €. The 52-week range spans from 8,05 € to 24,79 €; the current price is 64% below the yearly high. Year-over-year revenue growth stands at -7.2%.

💰 Dividende

Perrigo Company plc currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

4 analystes évaluent Perrigo Company plc (PRGO) au consensus : Acheter. L'objectif de cours moyen est de 14,38 €, soit un potentiel de +60.98% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 12,20 € à 17,44 €.

Perrigo Company plc : la thèse d'investissement en détail

Perrigo Company plc (PRGO) operates in the Healthcare — specifically Drug Manufacturers - Specialty & Generic — and is headquartered in Ireland. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Wall Street consensus sits at Buy with an average price target implying roughly 60.98% upside from current levels — analyst sentiment is firmly constructive.

Le scénario baissier

Revenue is contracting at -7.2% year-over-year — until that trend reverses, valuation is exposed to further downgrades. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. Short interest sits at 16.73% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

Valorisation en contexte

The PEG ratio at 1.14 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric. The EV/EBITDA multiple of 7.76x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

À surveiller

• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 60.98% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (16.73%), higher leverage relative to equity.

Trading Data

Related Stocks in the Same Sector

Where can I buy Perrigo Company plc?

Compare top-rated brokers — low fees, trusted providers, fully regulated.